Global Biosimilar Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 94

Published Date: 06 Jun 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Biosimilar Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Biosimilar Drug size is estimated to be XX million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Biosimilar Drug market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Biosimilar Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Injection
    Tablets
    Other Types

Market segment by Application can be divided into
    Ankylosing Spondylitis
    Tumor
    Rheumatoid Arthrtis
    Cardiovascular
    Other Application

The key market players for global Biosimilar Drug market are listed below:
    CP Guojian Pharma
    Biotech Pharma
    Celgen Pharma
    Henlius
    Amgen
    Eli Lilly
    Sandoz
    Changchun High Tech
    Innovent

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Biosimilar Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biosimilar Drug, with price, sales, revenue and global market share of Biosimilar Drug from 2019 to 2021.
Chapter 3, the Biosimilar Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilar Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Biosimilar Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Biosimilar Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Biosimilar Drug Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Biosimilar Drug Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Injection
        1.2.3 Tablets
        1.2.4 Other Types
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Biosimilar Drug Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Ankylosing Spondylitis
        1.3.3 Tumor
        1.3.4 Rheumatoid Arthrtis
        1.3.5 Cardiovascular
        1.3.6 Other Application
    1.4 Global Biosimilar Drug Market Size & Forecast
        1.4.1 Global Biosimilar Drug Sales in Value (2016-2026))
        1.4.2 Global Biosimilar Drug Sales in Volume (2016-2026)
        1.4.3 Global Biosimilar Drug Price by Type (2016-2026) & (USD/Dose)
    1.5 Global Biosimilar Drug Production Capacity Analysis
        1.5.1 Global Biosimilar Drug Total Production Capacity (2016-2026)
        1.5.2 Global Biosimilar Drug Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Biosimilar Drug Market Drivers
        1.6.2 Biosimilar Drug Market Restraints
        1.6.3 Biosimilar Drug Trends Analysis

2 Manufacturers Profiles
    2.1 CP Guojian Pharma
        2.1.1 CP Guojian Pharma Details
        2.1.2 CP Guojian Pharma Major Business
        2.1.3 CP Guojian Pharma Biosimilar Drug Product and Services
        2.1.4 CP Guojian Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Biotech Pharma
        2.2.1 Biotech Pharma Details
        2.2.2 Biotech Pharma Major Business
        2.2.3 Biotech Pharma Biosimilar Drug Product and Services
        2.2.4 Biotech Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Celgen Pharma
        2.3.1 Celgen Pharma Details
        2.3.2 Celgen Pharma Major Business
        2.3.3 Celgen Pharma Biosimilar Drug Product and Services
        2.3.4 Celgen Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Henlius
        2.4.1 Henlius Details
        2.4.2 Henlius Major Business
        2.4.3 Henlius Biosimilar Drug Product and Services
        2.4.4 Henlius Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Amgen
        2.5.1 Amgen Details
        2.5.2 Amgen Major Business
        2.5.3 Amgen Biosimilar Drug Product and Services
        2.5.4 Amgen Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Eli Lilly
        2.6.1 Eli Lilly Details
        2.6.2 Eli Lilly Major Business
        2.6.3 Eli Lilly Biosimilar Drug Product and Services
        2.6.4 Eli Lilly Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Sandoz
        2.7.1 Sandoz Details
        2.7.2 Sandoz Major Business
        2.7.3 Sandoz Biosimilar Drug Product and Services
        2.7.4 Sandoz Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 Changchun High Tech
        2.8.1 Changchun High Tech Details
        2.8.2 Changchun High Tech Major Business
        2.8.3 Changchun High Tech Biosimilar Drug Product and Services
        2.8.4 Changchun High Tech Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 Innovent
        2.9.1 Innovent Details
        2.9.2 Innovent Major Business
        2.9.3 Innovent Biosimilar Drug Product and Services
        2.9.4 Innovent Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Biosimilar Drug Sales by Manufacturer
    3.1 Global Biosimilar Drug Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Biosimilar Drug Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Biosimilar Drug
    3.4 Market Concentration Rate
        3.4.1 Top 3 Biosimilar Drug Manufacturer Market Share
        3.4.2 Top 6 Biosimilar Drug Manufacturer Market Share
    3.5 Global Biosimilar Drug Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Biosimilar Drug Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Biosimilar Drug Market Size by Region
        4.1.1 Global Biosimilar Drug Sales in Volume by Region (2016-2026)
        4.1.2 Global Biosimilar Drug Revenue by Region (2016-2026)
    4.2 North America Biosimilar Drug Revenue (2016-2026)
    4.3 Europe Biosimilar Drug Revenue (2016-2026)
    4.4 Asia-Pacific Biosimilar Drug Revenue (2016-2026)
    4.5 South America Biosimilar Drug Revenue (2016-2026)
    4.6 Middle East and Africa Biosimilar Drug Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Biosimilar Drug Sales in Volume by Type (2016-2026)
    5.2 Global Biosimilar Drug Revenue by Type (2016-2026)
    5.3 Global Biosimilar Drug Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Biosimilar Drug Sales in Volume by Application (2016-2026)
    6.2 Global Biosimilar Drug Revenue by Application (2016-2026)
    6.3 Global Biosimilar Drug Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Biosimilar Drug Sales by Type (2016-2026)
    7.2 North America Biosimilar Drug Sales by Application (2016-2026)
    7.3 North America Biosimilar Drug Market Size by Country
        7.3.1 North America Biosimilar Drug Sales in Volume by Country (2016-2026)
        7.3.2 North America Biosimilar Drug Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Biosimilar Drug Sales by Type (2016-2026)
    8.2 Europe Biosimilar Drug Sales by Application (2016-2026)
    8.3 Europe Biosimilar Drug Market Size by Country
        8.3.1 Europe Biosimilar Drug Sales in Volume by Country (2016-2026)
        8.3.2 Europe Biosimilar Drug Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Biosimilar Drug Sales by Type (2016-2026)
    9.2 Asia-Pacific Biosimilar Drug Sales by Application (2016-2026)
    9.3 Asia-Pacific Biosimilar Drug Market Size by Region
        9.3.1 Asia-Pacific Biosimilar Drug Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Biosimilar Drug Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Biosimilar Drug Sales by Type (2016-2026)
    10.2 South America Biosimilar Drug Sales by Application (2016-2026)
    10.3 South America Biosimilar Drug Market Size by Country
        10.3.1 South America Biosimilar Drug Sales in Volume by Country (2016-2026)
        10.3.2 South America Biosimilar Drug Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Biosimilar Drug Sales by Type (2016-2026)
    11.2 Middle East & Africa Biosimilar Drug Sales by Application (2016-2026)
    11.3 Middle East & Africa Biosimilar Drug Market Size by Country
        11.3.1 Middle East & Africa Biosimilar Drug Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Biosimilar Drug Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Biosimilar Drug Typical Distributors
    12.3 Biosimilar Drug Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Biosimilar Drug Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Biosimilar Drug Revenue by Application, (USD Million), 2021-2026
    Table 3. CP Guojian Pharma Basic Information, Manufacturing Base and Competitors
    Table 4. CP Guojian Pharma Major Business
    Table 5. CP Guojian Pharma Biosimilar Drug Product and Services
    Table 6. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. Biotech Pharma Basic Information, Manufacturing Base and Competitors
    Table 8. Biotech Pharma Major Business
    Table 9. Biotech Pharma Biosimilar Drug Product and Services
    Table 10. Biotech Pharma Biosimilar Drug Sales (K Dose), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Celgen Pharma Basic Information, Manufacturing Base and Competitors
    Table 12. Celgen Pharma Major Business
    Table 13. Celgen Pharma Biosimilar Drug Product and Services
    Table 14. Celgen Pharma Biosimilar Drug Sales (K Dose), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Henlius Basic Information, Manufacturing Base and Competitors
    Table 16. Henlius Major Business
    Table 17. Henlius Biosimilar Drug Product and Services
    Table 18. Henlius Biosimilar Drug Sales (K Dose), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Amgen Basic Information, Manufacturing Base and Competitors
    Table 20. Amgen Major Business
    Table 21. Amgen Biosimilar Drug Product and Services
    Table 22. Amgen Biosimilar Drug Sales (K Dose), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table 24. Eli Lilly Major Business
    Table 25. Eli Lilly Biosimilar Drug Product and Services
    Table 26. Eli Lilly Biosimilar Drug Sales (K Dose), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. Sandoz Basic Information, Manufacturing Base and Competitors
    Table 28. Sandoz Major Business
    Table 29. Sandoz Biosimilar Drug Product and Services
    Table 30. Sandoz Biosimilar Drug Sales (K Dose), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. Changchun High Tech Basic Information, Manufacturing Base and Competitors
    Table 32. Changchun High Tech Major Business
    Table 33. Changchun High Tech Biosimilar Drug Product and Services
    Table 34. Changchun High Tech Biosimilar Drug Sales (K Dose), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. Innovent Basic Information, Manufacturing Base and Competitors
    Table 36. Innovent Major Business
    Table 37. Innovent Biosimilar Drug Product and Services
    Table 38. Innovent Biosimilar Drug Sales (K Dose), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. Global Biosimilar Drug Sales by Manufacturer (2019-2021e) & (K Dose)
    Table 40. Global Biosimilar Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 41. Market Position of Manufacturers in Biosimilar Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 42. Global Biosimilar Drug Production Capacity by Company, (K Dose): 2020 VS 2021
    Table 43. Head Office and Biosimilar Drug Production Site of Key Manufacturer
    Table 44. Biosimilar Drug New Entrant and Capacity Expansion Plans
    Table 45. Biosimilar Drug Mergers & Acquisitions in the Past Five Years
    Table 46. Global Biosimilar Drug Sales by Region (2016-2021e) & (K Dose)
    Table 47. Global Biosimilar Drug Sales by Region (2021-2026) & (K Dose)
    Table 48. Global Biosimilar Drug Revenue by Region (2016-2021e) & (USD Million)
    Table 49. Global Biosimilar Drug Revenue by Region (2021-2026) & (USD Million)
    Table 50. Global Biosimilar Drug Sales by Type (2016-2021e) & (K Dose)
    Table 51. Global Biosimilar Drug Sales by Type (2021-2026) & (K Dose)
    Table 52. Global Biosimilar Drug Revenue by Type (2016-2021e) & (USD Million)
    Table 53. Global Biosimilar Drug Revenue by Type (2021-2026) & (USD Million)
    Table 54. Global Biosimilar Drug Price by Type (2016-2021e) & (USD/Dose)
    Table 55. Global Biosimilar Drug Price by Type (2021-2026) & (USD/Dose)
    Table 56. Global Biosimilar Drug Sales by Application (2016-2021e) & (K Dose)
    Table 57. Global Biosimilar Drug Sales by Application (2021-2026) & (K Dose)
    Table 58. Global Biosimilar Drug Revenue by Application (2016-2021e) & (USD Million)
    Table 59. Global Biosimilar Drug Revenue by Application (2021-2026) & (USD Million)
    Table 60. Global Biosimilar Drug Price by Application (2016-2021e) & (USD/Dose)
    Table 61. Global Biosimilar Drug Price by Application (2021-2026) & (USD/Dose)
    Table 62. North America Biosimilar Drug Sales by Country (2016-2021e) & (K Dose)
    Table 63. North America Biosimilar Drug Sales by Country (2021-2026) & (K Dose)
    Table 64. North America Biosimilar Drug Revenue by Country (2016-2021e) & (USD Million)
    Table 65. North America Biosimilar Drug Revenue by Country (2021-2026) & (USD Million)
    Table 66. North America Biosimilar Drug Sales by Type (2016-2021e) & (K Dose)
    Table 67. North America Biosimilar Drug Sales by Type (2021-2026) & (K Dose)
    Table 68. North America Biosimilar Drug Sales by Application (2016-2021e) & (K Dose)
    Table 69. North America Biosimilar Drug Sales by Application (2021-2026) & (K Dose)
    Table 70. Europe Biosimilar Drug Sales by Country (2016-2021e) & (K Dose)
    Table 71. Europe Biosimilar Drug Sales by Country (2021-2026) & (K Dose)
    Table 72. Europe Biosimilar Drug Revenue by Country (2016-2021e) & (USD Million)
    Table 73. Europe Biosimilar Drug Revenue by Country (2021-2026) & (USD Million)
    Table 74. Europe Biosimilar Drug Sales by Type (2016-2021e) & (K Dose)
    Table 75. Europe Biosimilar Drug Sales by Type (2021-2026) & (K Dose)
    Table 76. Europe Biosimilar Drug Sales by Application (2016-2021e) & (K Dose)
    Table 77. Europe Biosimilar Drug Sales by Application (2021-2026) & (K Dose)
    Table 78. Asia-Pacific Biosimilar Drug Sales by Region (2016-2021e) & (K Dose)
    Table 79. Asia-Pacific Biosimilar Drug Sales by Region (2021-2026) & (K Dose)
    Table 80. Asia-Pacific Biosimilar Drug Revenue by Region (2016-2021e) & (USD Million)
    Table 81. Asia-Pacific Biosimilar Drug Revenue by Region (2021-2026) & (USD Million)
    Table 82. Asia-Pacific Biosimilar Drug Sales by Type (2016-2021e) & (K Dose)
    Table 83. Asia-Pacific Biosimilar Drug Sales by Type (2021-2026) & (K Dose)
    Table 84. Asia-Pacific Biosimilar Drug Sales by Application (2016-2021e) & (K Dose)
    Table 85. Asia-Pacific Biosimilar Drug Sales by Application (2021-2026) & (K Dose)
    Table 86. South America Biosimilar Drug Sales by Country (2016-2021e) & (K Dose)
    Table 87. South America Biosimilar Drug Sales by Country (2021-2026) & (K Dose)
    Table 88. South America Biosimilar Drug Revenue by Country (2016-2021e) & (USD Million)
    Table 89. South America Biosimilar Drug Revenue by Country (2021-2026) & (USD Million)
    Table 90. South America Biosimilar Drug Sales by Type (2016-2021e) & (K Dose)
    Table 91. South America Biosimilar Drug Sales by Type (2021-2026) & (K Dose)
    Table 92. South America Biosimilar Drug Sales by Application (2016-2021e) & (K Dose)
    Table 93. South America Biosimilar Drug Sales by Application (2021-2026) & (K Dose)
    Table 94. Middle East & Africa Biosimilar Drug Sales by Country (2016-2021e) & (K Dose)
    Table 95. Middle East & Africa Biosimilar Drug Sales by Country (2021-2026) & (K Dose)
    Table 96. Middle East & Africa Biosimilar Drug Revenue by Country (2016-2021e) & (USD Million)
    Table 97. Middle East & Africa Biosimilar Drug Revenue by Country (2021-2026) & (USD Million)
    Table 98. Middle East & Africa Biosimilar Drug Sales by Type (2016-2021e) & (K Dose)
    Table 99. Middle East & Africa Biosimilar Drug Sales by Type (2021-2026) & (K Dose)
    Table 100. Middle East & Africa Biosimilar Drug Sales by Application (2016-2021e) & (K Dose)
    Table 101. Middle East & Africa Biosimilar Drug Sales by Application (2021-2026) & (K Dose)
    Table 102. Direct Channel Pros & Cons
    Table 103. Indirect Channel Pros & Cons
    Table 104. Biosimilar Drug Typical Distributors
    Table 105. Biosimilar Drug Typical Customers
List of Figures
    Figure 1. Biosimilar Drug Picture
    Figure 2. Global Biosimilar Drug Sales Market Share by Type in 2020
    Figure 3. Injection
    Figure 4. Tablets
    Figure 5. Other Types
    Figure 6. Global Biosimilar Drug Sales Market Share by Application in 2020
    Figure 7. Ankylosing Spondylitis
    Figure 8. Tumor
    Figure 9. Rheumatoid Arthrtis
    Figure 10. Cardiovascular
    Figure 11. Other Application
    Figure 12. Global Biosimilar Drug Market Size, (USD Million) & (K Dose): 2020 VS 2021 VS 2026
    Figure 13. Global Biosimilar Drug Market Size and Forecast (2016-2026) & (USD Million)
    Figure 14. Global Biosimilar Drug Sales (2016-2026) & (K Dose)
    Figure 15. Global Biosimilar Drug Price by Type (2016-2026) & (USD/Dose)
    Figure 16. Global Biosimilar Drug Production Capacity (2016-2026) & (K Dose)
    Figure 17. Global Biosimilar Drug Production Capacity by Geographic Region: 2020 VS 2021
    Figure 18. Biosimilar Drug Market Drivers
    Figure 19. Biosimilar Drug Market Restraints
    Figure 20. Biosimilar Drug Market Trends
    Figure 21. Global Biosimilar Drug Sales Market Share by Manufacturer in 2020
    Figure 22. Global Biosimilar Drug Revenue Market Share by Manufacturer in 2020
    Figure 23. Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 24. Top 3 Biosimilar Drug Manufacturer (Revenue) Market Share in 2020
    Figure 25. Top 6 Biosimilar Drug Manufacturer (Revenue) Market Share in 2020
    Figure 26. Global Biosimilar Drug Sales Market Share by Region (2016-2026)
    Figure 27. Global Biosimilar Drug Revenue Market Share by Region (2016-2026)
    Figure 28. North America Biosimilar Drug Revenue (2016-2026) & (USD Million)
    Figure 29. Europe Biosimilar Drug Revenue (2016-2026) & (USD Million)
    Figure 30. Asia-Pacific Biosimilar Drug Revenue (2016-2026) & (USD Million)
    Figure 31. South America Biosimilar Drug Revenue (2016-2026) & (USD Million)
    Figure 32. Middle East & Africa Biosimilar Drug Revenue (2016-2026) & (USD Million)
    Figure 33. Global Biosimilar Drug Sales Market Share by Type (2016-2026)
    Figure 34. Global Biosimilar Drug Revenue Market Share by Type (2016-2026)
    Figure 35. Global Biosimilar Drug Price by Type (2016-2026) & (USD/Dose)
    Figure 36. Global Biosimilar Drug Sales Market Share by Application (2016-2026)
    Figure 37. Global Biosimilar Drug Revenue Market Share by Application (2016-2026)
    Figure 38. Global Biosimilar Drug Price by Application (2016-2026) & (USD/Dose)
    Figure 39. North America Biosimilar Drug Sales Market Share by Type (2016-2026)
    Figure 40. North America Biosimilar Drug Sales Market Share by Application (2016-2026)
    Figure 41. North America Biosimilar Drug Sales Market Share by Country (2016-2026)
    Figure 42. North America Biosimilar Drug Revenue Market Share by Country (2016-2026)
    Figure 43. United States Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 44. Canada Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 45. Mexico Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 46. Europe Biosimilar Drug Sales Market Share by Type (2016-2026)
    Figure 47. Europe Biosimilar Drug Sales Market Share by Application (2016-2026)
    Figure 48. Europe Biosimilar Drug Sales Market Share by Country (2016-2026)
    Figure 49. Europe Biosimilar Drug Revenue Market Share by Country (2016-2026)
    Figure 50. Germany Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. France Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. United Kingdom Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Russia Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. Italy Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. Asia-Pacific Biosimilar Drug Sales Market Share by Region (2016-2026)
    Figure 56. Asia-Pacific Biosimilar Drug Sales Market Share by Application (2016-2026)
    Figure 57. Asia-Pacific Biosimilar Drug Sales Market Share by Region (2016-2026)
    Figure 58. Asia-Pacific Biosimilar Drug Revenue Market Share by Region (2016-2026)
    Figure 59. China Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Japan Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Korea Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. India Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Southeast Asia Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Australia Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. South America Biosimilar Drug Sales Market Share by Type (2016-2026)
    Figure 66. South America Biosimilar Drug Sales Market Share by Application (2016-2026)
    Figure 67. South America Biosimilar Drug Sales Market Share by Country (2016-2026)
    Figure 68. South America Biosimilar Drug Revenue Market Share by Country (2016-2026)
    Figure 69. Brazil Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. Argentina Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 71. Middle East & Africa Biosimilar Drug Sales Market Share by Type (2016-2026)
    Figure 72. Middle East & Africa Biosimilar Drug Sales Market Share by Application (2016-2026)
    Figure 73. Middle East & Africa Biosimilar Drug Sales Market Share by Country (2016-2026)
    Figure 74. Middle East & Africa Biosimilar Drug Revenue Market Share by Country (2016-2026)
    Figure 75. Turkey Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. Egypt Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. Saudi Arabia Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. South Africa Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. Sales Channel: Direct Channel vs Indirect Channel
    Figure 80. Methodology
    Figure 81. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius
Amgen
Eli Lilly
Sandoz
Changchun High Tech
Innovent

Related Reports

Global Biosimilar Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Biosimilar Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Pharma & Healthcare

The Biosimilar Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Biosimilar Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Biosimilar Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.

Global Biosimilar Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Biosimilar Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Biosimilar Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Biosimilar Drug Supply, Demand and Key Producers, 2024-2030

Global Biosimilar Drug Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Pharma & Healthcare

The global Biosimilar Drug market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>